Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Glucagon‐like peptide‐1 effect on β‐cell function varies according to diabetes remission status after Roux‐en‐Y gastric bypass

Diabetes Obesity and Metabolism(2022)10.1111/dom.14793Source: DataRank Database

Glucagon‐like peptide‐1 effect on β‐cell function varies according to diabetes remission status after Roux‐en‐Y gastric bypass is a research paper published in Diabetes Obesity and Metabolism (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.68)OA: greenTopics (42)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Malini Prasad ORCID,Victoria Mark,Jens J. Holst ORCID,Blandine Laferrère ORCID,Ankit Shah ORCID

Live enrichment

PubMed:35676799 PMC:PMC9595602 OpenAlex:https://openalex.org/W4282045151

National Center for Advancing Translational Sciences

Grant: UL1TR000040

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: F32DK113747

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: P30DK063608

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: P30DK26687

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01DK098056

NIDDK NIH HHS

Grant: P30 DK026687

FWCI

1.68

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

greenLicense: cc-by-nc

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9595602

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14793

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/dom.14793

publisherhttps://dom-pubs.pericles-prod.literatumonline.com/doi/pdf/10.1111/dom.14793

Fields of Study

Bariatric Surgery and OutcomesDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsBlood GlucoseDiabetes Mellitus, Type 2Gastric BypassGlucagonGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorGlucoseGlucose IntoleranceHumansInsulinRetrospective Studies

MeSH Terms

Glucagon-Like Peptide-1 ReceptorBlood GlucoseDiabetes Mellitus, Type 2GlucagonGlucoseHumansInsulinRetrospective StudiesGastric BypassGlucose IntoleranceGlucagon-Like Peptide 1

Keywords

MedicineGastric bypassGlucagon-like peptide-1Roux-en-Y anastomosisInternal medicineDiabetes mellitusGastric bypass surgeryGlucagonEndocrinologyType 2 diabetesGastroenterologyInsulinObesityWeight lossRemissionIncretinsB-cell Function

Sustainable Development Goals

SDG 0: Good health and well-being